Pleomorphic adenoma gene 1 (PLAG1) promotes proliferation and inhibits apoptosis of bovine primary myoblasts through the PI3K-Akt signaling pathway.
Jian WangYongzhen HuangJiawei XuBinglin YueYifan WenXiao WangChu-Zhao LeiHong ChenPublished in: Journal of animal science (2022)
Pleomorphic adenoma gene 1 (PLAG1) is a transcription factor involved in various cellular processes in organismal growth and development. However, its role in muscle function is unclear. This work investigated the roles of PLAG1 in muscle development and explored its regulatory mechanisms. The PLAG1 was proved to promote the proliferation of bovine primary myoblasts using the cell counting kit 8 (CCK-8) assay (P < 0.001), 5-ethynyl-2'-deoxyuridine (EdU) proliferation assay (P = 0.005), quantitative real-time polymerase chain reaction (qRT-PCR) (P = 0.028), western blot, and flow cytometry (P < 0.05), and to inhibit apoptosis of bovine primary myoblasts using qRT-PCR (P = 0.038), western blot, and flow cytometry (P < 0.001). Chromatin immunoprecipitation sequencing (ChIP-seq) and western blot showed PLAG1 upregulated phosphorylated (p)-PI3K, PI3K, p-Akt, Akt, Cyclin D1, and CDK2 and inhibited the expression of p21 and p27 to enhance myoblast proliferation, and increased expression of Bcl-2, and Bcl-xL to inhibit apoptosis. Additionally, PLAG1 was identified as a target of miR-1 using dual-luciferase assay (P < 0.001), qRT-PCR (P < 0.001), and western blot. Furthermore, miR-1 might be a potential mediator of the positive feedback regulation relationship between PLAG1 and the PI3K-Akt signaling pathway.
Keyphrases
- signaling pathway
- flow cytometry
- pi k akt
- cell cycle arrest
- transcription factor
- high throughput
- cell proliferation
- single cell
- genome wide
- induced apoptosis
- poor prognosis
- south africa
- endoplasmic reticulum stress
- oxidative stress
- long non coding rna
- epithelial mesenchymal transition
- cell death
- cell cycle
- copy number
- gene expression
- genome wide identification
- dna damage
- long noncoding rna
- rna seq
- real time pcr
- mesenchymal stem cells
- risk assessment
- cell therapy
- circulating tumor cells
- mass spectrometry
- atomic force microscopy
- high speed